Orbimed Advisors Trims $125 After Breakout Year in Biotech
A major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
Indices enable broad exposure across sectors and regions, helping you diversify efficiently. This reduces idiosyncratic risk while maintaining growth opportunities.
14,037 articlesA major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
A director sold about $128,000 of Cognex shares, prompting questions about the stock's outlook. This guide breaks dow...
As companies report, global grow 2026 earnings becomes a key lens on global demand, margins, and cash flow. This guid...
As investors eye the next earnings cycle, Sweetgreen's 2025 earnings outlook becomes a focal point for growth, margin...
Netflix stock surged last Friday on news that the company walked away from a mega-deal. This guide explains what happ...
Leveraged ETFs promise outsized gains, but they are built for daily moves, not long-term investing. This guide breaks...
As Baidu surges, a hedge fund’s multi-million bet raises questions about AI, China’s digital economy, and portfolio c...
Novo Nordisk faces intense pressure in the fast-growing obesity treatment space. This article dives into whether this...
A major move by hedge fund incline global to liquidate its Maplebear stake prompts a closer look at CART stock. Read ...
When CPSS releases its earnings, it can move the stock and shape investor sentiment for months. This guide breaks dow...
Investors are watching CoreWeave's stock slide after a rapid rise. This guide breaks down whether the dip is a buying...
A record Bitcoin buy signals a shift in 2026. Big buyers are reshaping STRC demand and influencing crypto markets. He...